Penack, O., Peczynski, C., Koenecke, C., Polge, E., Kuhnl, A., Fegueux, N. ... Perić, Z. (2023). Severe cytopenia after CD19 CAR T-cell therapy: a retrospective study from the EBMT Transplant Complications Working Party. Journal for ImmunoTherapy of Cancer, 11. (4). doi: 10.1136/jitc-2022-006406
Penack, Olaf, et al. "Severe cytopenia after CD19 CAR T-cell therapy: a retrospective study from the EBMT Transplant Complications Working Party." Journal for ImmunoTherapy of Cancer, vol. 11, no. 4, 2023. https://doi.org/10.1136/jitc-2022-006406
Penack, Olaf, Christophe Peczynski, Christian Koenecke, Emmanuelle Polge, Andrea Kuhnl, Nathalie Fegueux, Michael Daskalakis, et al. "Severe cytopenia after CD19 CAR T-cell therapy: a retrospective study from the EBMT Transplant Complications Working Party." Journal for ImmunoTherapy of Cancer 11, no. 4 (2023). https://doi.org/10.1136/jitc-2022-006406
Penack, O., et al. (2023) 'Severe cytopenia after CD19 CAR T-cell therapy: a retrospective study from the EBMT Transplant Complications Working Party', Journal for ImmunoTherapy of Cancer, 11(4). doi: 10.1136/jitc-2022-006406
Penack O, Peczynski C, Koenecke C, Polge E, Kuhnl A, Fegueux N, and sur.. Severe cytopenia after CD19 CAR T-cell therapy: a retrospective study from the EBMT Transplant Complications Working Party. Journal for ImmunoTherapy of Cancer [Internet]. 2023 April [cited 2024 August 18];11(4). doi: 10.1136/jitc-2022-006406
O. Penack, et al., "Severe cytopenia after CD19 CAR T-cell therapy: a retrospective study from the EBMT Transplant Complications Working Party", Journal for ImmunoTherapy of Cancer, vol. 11, no. 4, April 2023. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:867008. [Accessed: 18 August 2024]